Stock Comparison

BBIO vs REGN

BridgeBio Pharma Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BBIO

BridgeBio Pharma Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$13.76B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

—

14.1

Price/Sales

23.7

4.5

Price/Book

123.7

2.1

EV/EBITDA

-9.4

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-124.40%

29.60%

Operating Margin

-54.50%

20.70%

Return on Equity

-1790.00%

14.50%

Return on Assets

-28.00%

6.13%

Growth (YoY)

Revenue Growth

66.80%

19.00%

Earnings Growth

0.00%

-7.20%

Price & Risk

Beta

1.0

0.2

52-Week High

$84.94

$818.90

52-Week Low

$41.80

$516.07

Analyst Target

$102.28

$833.31

Compare BBIO and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.